AbbVie's Options Frenzy: What You Need to Know
Portfolio Pulse from Benzinga Insights
AbbVie (NYSE:ABBV) has seen a significant amount of options trading activity, with a bearish sentiment prevailing among investors. Analysis of 13 trades shows a split with 38% bullish and 61% bearish positions. The trading focused on a price range between $85.0 and $177.5. The largest trades include both puts and calls with varying sentiments and strike prices. AbbVie, a pharmaceutical company, has its stock currently up by 0.22% at $162.63. Analysts from Guggenheim and Barclays have issued buy and overweight ratings with target prices of $190 and $195, respectively.
April 15, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AbbVie has seen a mix of bullish and bearish options trading, with current stock price slightly up. Analysts remain positive, setting high target prices.
The bearish options sentiment is countered by a slight increase in stock price and positive analyst ratings, suggesting a potential short-term upward movement in stock price despite the bearish trading activity.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100